Mobile

A Phase II Study to determine the efficacy and safety of conventional dose oral Treosulfan in patients with advanced pre-treated Ewing’s Sarcoma

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-003254-10

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The main objective of this trial is to determine the effectiveness of oral treosulfan in patients with advanced pre-treated Ewing's Sarcoma.

Critère d'inclusion

  • Advanced and pre-treated Ewing’s Sarcoma

Liens